These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33837453)

  • 1. Frontiers of therapy for hepatocellular carcinoma.
    Heller M; Parikh ND; Fidelman N; Owen D
    Abdom Radiol (NY); 2021 Aug; 46(8):3648-3659. PubMed ID: 33837453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective.
    Kim GH; Kim JH; Kim PH; Chu HH; Gwon DI; Ko HK
    Korean J Radiol; 2021 Nov; 22(11):1822-1833. PubMed ID: 34431250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.
    Mu L; Chapiro J; Stringam J; Geschwind JF
    Cancer J; 2016; 22(6):365-372. PubMed ID: 27870678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifocal hepatocellular carcinoma: Magnetic resonance imaging features after transarterial embolization.
    Picchia S; Bali MA
    Curr Probl Cancer; 2018; 42(3):319-321. PubMed ID: 29729826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional therapy of hepatocellular carcinoma.
    Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
    Clin Liver Dis; 2015 May; 19(2):401-20. PubMed ID: 25921670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review.
    Alnammi M; Wortman J; Therrien J; Afnan J
    Abdom Radiol (NY); 2022 Jul; 47(7):2299-2313. PubMed ID: 35524803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma with Intra-atrial Tumor Extension: Imaging Response and Oncologic Outcomes.
    Kolarich A; Frangakis C; Yarchoan M; Hong K; Georgiades C
    J Vasc Interv Radiol; 2021 Aug; 32(8):1203-1208.e1. PubMed ID: 34332718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma.
    Saake M; Seuss H; Hammon M; Ellmann S; May M; Uder M; Schmid A
    Acta Radiol; 2020 Feb; 61(2):148-155. PubMed ID: 31189328
    [No Abstract]   [Full Text] [Related]  

  • 10. 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What's New?
    Lee IJ; Chun HJ; Chung JW
    Korean J Radiol; 2023 Jan; 24(1):6-9. PubMed ID: 36606613
    [No Abstract]   [Full Text] [Related]  

  • 11. In Vivo Proof of Superselective Transarterial Chemoembolization with 40-μm Drug-Eluting Beads in a Patient with Hepatocellular Carcinoma.
    She HL; Burgmans MC; Coenraadm M; Saraqueta AF
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):137-40. PubMed ID: 26085369
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver-directed therapy for hepatocellular carcinoma.
    Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC
    Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the response to locoregional and systemic treatment for hepatocellular carcinoma.
    Darnell A; Belmonte E; Reig M; Brú C
    Radiologia (Engl Ed); 2018; 60(5):424-436. PubMed ID: 30196841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Helmberger T; Pereira PL
    Radiologe; 2022 Mar; 62(3):234-238. PubMed ID: 35171313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma].
    Jung EM; Uller W; Stroszczynski C; Clevert DA
    Radiologe; 2011 Jun; 51(6):462-8. PubMed ID: 21557022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN
    J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A step toward a better understanding of hepatocellular progression after transarterial embolization.
    Dohan A; Barat M; Coriat R; Soyer P
    Diagn Interv Imaging; 2022 Mar; 103(3):125-126. PubMed ID: 35153170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.